No difference in plasma fibrinogen levels between CAPD patients taking atorvastatin and simvastatin.
Singhal
M K
MK
Bhaskaran
S
S
Szabo
T
T
La Rosa
R
R
D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000069059:Atorvastatin; D002318:Cardiovascular Diseases / Q000517:prevention & control; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D005340:Fibrinogen / Q000032:analysis*; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy*; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D011758:Pyrroles / Q000627:therapeutic use*; D012307:Risk Factors; D019821:Simvastatin / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D014280:Triglycerides; D005340:Fibrinogen; D002784:Cholesterol; D000069059:Atorvastatin; D019821:Simvastatin